NASDAQ:DFNS Nukkleus (DFNS) Stock Price, News & Analysis $1.68 -0.21 (-11.11%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Nukkleus Stock (NASDAQ:DFNS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nukkleus alerts:Sign Up Key Stats Today's Range$1.64▼$1.7950-Day Range$1.89▼$10.2452-Week Range$1.64▼$930.00Volume430,350 shsAverage Volume1.19 million shsMarket Capitalization$2.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingModerate Buy Company Overview Nukkleus is a technology company that has historically provided software and related services for the foreign-exchange industry. Its offerings have included trading and payment technology used by brokers and other financial-services businesses. The company has more recently shifted its strategic focus toward defense and security. Public information about its current product portfolio and operating activities is limited, so specific products and geographic markets are not described here.AI Generated. May Contain Errors. Read More Nukkleus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks25th Percentile Overall ScoreDFNS MarketRank™: 1.22597746852 of 5 starsNukkleus scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingModerate Buy Consensus RatingNukkleus has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageNukkleus has only been the subject of 1 research reports in the past 90 days.Read more about Nukkleus' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Nukkleus are expected to grow in the coming year, from ($3.90) to ($3.21) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nukkleus is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nukkleus is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted29.86% of the float of Nukkleus has been sold short.Short Interest Ratio / Days to CoverNukkleus has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nukkleus has recently decreased by 9.87%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNukkleus does not currently pay a dividend.Dividend GrowthNukkleus does not have a long track record of dividend growth. News and Social Media2.3 / 5News Sentiment0.61 News SentimentNukkleus has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Industrials companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Nukkleus this week, compared to 3 articles on an average week.MarketBeat Follows1 people have added Nukkleus to their MarketBeat watchlist in the last 30 days. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nukkleus insiders have not sold or bought any company stock.Percentage Held by Insiders11.14% of the stock of Nukkleus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions12.47% of the stock of Nukkleus is held by institutions.Read more about Nukkleus' insider trading history. Receive DFNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nukkleus and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DFNS Stock News HeadlinesT3 Defense Completes First Aerostat Surveillance Deployment at Mexican Federal Prison FacilityNovember 16 at 9:10 AM | globenewswire.comT3 Defense Secures Exclusive Israeli Distribution Rights for Copting GmbH Tethered Drone SystemNovember 11, 2026 | globenewswire.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 16 at 1:00 AM | Weiss Ratings (Ad)Nukkleus (DFNS) vs. The Competition Financial SurveyNovember 8, 2026 | americanbankingnews.comT3 Defense Delivers a UAV Command & Control Center to BlueBird Aero SystemsNovember 5, 2026 | globenewswire.comT3 Defense to Launch TOPS-NX Studio and SILOS at I/ITSEC 2026November 3, 2026 | globenewswire.comT3 Defense Enters Agreement to Acquire KeepZone AIOctober 27, 2026 | globenewswire.comT3 Defense Delivers Mobile UAV Command-and-Control Vehicle to Israeli HLS OperatorOctober 22, 2026 | globenewswire.comSee More Headlines DFNS Stock Analysis - Frequently Asked Questions How have DFNS shares performed this year? Nukkleus' stock was trading at $503.75 at the start of the year. Since then, DFNS shares have decreased by 99.7% and is now trading at $1.71. How were Nukkleus' earnings last quarter? Nukkleus Inc. (NASDAQ:DFNS) posted its earnings results on Wednesday, August, 19th. The company reported ($173.80) earnings per share for the quarter, missing analysts' consensus estimates of ($3.11) by $170.69. The business earned $4.00 million during the quarter, compared to the consensus estimate of $4.50 million. When did Nukkleus' stock split? Nukkleus shares reverse split on Thursday, October 24th 2024.The 1-8 reverse split was announced on Friday, October 18th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of Nukkleus? Shares of DFNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nukkleus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nukkleus investors own include SoundHound AI (SOUN), D-Wave Quantum (QBTS), NVIDIA (NVDA), Micron Technology (MU), Rigetti Computing (RGTI), BigBear.ai (BBAI) and Lithium Americas (LAC). Company Calendar Last Earnings8/19/2026Today11/16/2026EGM 202611/30/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrials Industry Aerospace & Defense Sub-IndustryAerospace & Defense Current SymbolNASDAQ:DFNS Previous SymbolNASDAQ:NUKK CIK1787518 Webwww.nukk.com Phone212-791-4663FaxN/AEmployees12Year Founded2013Profitability EPS (Trailing Twelve Months)($397.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$78.55 million Net MarginsN/A Pretax Margin-1,854.62% Return on EquityN/A Return on Assets-26.92% Debt Debt-to-Equity Ratio0.07 Current Ratio0.14 Quick Ratio0.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($90.93) per share Price / Book-0.02Miscellaneous Outstanding Shares1,664,000Free Float1,622,000Market Cap$2.80 million OptionableN/A Beta-6.00 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:DFNS) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredFDA clears next-gen therapy with 10 to 40 times greater potencyTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nukkleus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nukkleus With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.